compendium.ch

Signifor/Signifor LAR (pasiréotide)

09.05.2025

RMP Summary

Un résumé du plan de gestion des risques (RMP, Risk Management Plan) pour Signifor/Signifor LAR a été publié par Swissmedic.

pasireotide (Signifor)® RMP Summary

Produit
Description

Firme

Emballage le plus petit

Prix
CHF

Cat. de remise
Cat. de remboursement

SIGNIFOR LAR subst sèche 10 mg cum solv

H01CB05 Pasiréotide

Recordati AG flacon 1 pce

SIGNIFOR LAR subst sèche 20 mg cum solv

H01CB05 Pasiréotide

Recordati AG flacon 1 pce

A
LS: quote-part normale: 10% (LIM)

SIGNIFOR LAR subst sèche 30 mg cum solv

H01CB05 Pasiréotide

Recordati AG flacon 1 pce

SIGNIFOR LAR subst sèche 40 mg cum solv

H01CB05 Pasiréotide

Recordati AG flacon 1 pce

A
LS: quote-part normale: 10% (LIM)

SIGNIFOR LAR subst sèche 60 mg cum solv

H01CB05 Pasiréotide

Recordati AG flacon 1 pce

A
LS: quote-part normale: 10% (LIM)

SIGNIFOR sol inj 0.3 mg/ml

H01CB05 Pasiréotide

Recordati AG 30 ampoules x 1 ml

B
LS: quote-part normale: 10% (LIM)

SIGNIFOR sol inj 0.6 mg/ml

H01CB05 Pasiréotide

Recordati AG 30 ampoules x 1 ml

B
LS: quote-part normale: 10% (LIM)

SIGNIFOR sol inj 0.9 mg/ml

H01CB05 Pasiréotide

Recordati AG 30 ampoules x 1 ml

B
LS: quote-part normale: 10% (LIM)